2500 TG Omega-3 (Mini Softgel) - 3 Pack
Smallest Omega-3 Capsules Available!
- Concentrated Triglyceride Form of Omega-3
- 375 mg of Ultra-Refined EPA & DHA Omega-3 per softgel
- No Fishy Aftertaste or Fish Burps
- No Shellfish Allergens
- Easy-to-Swallow Mini Softgels
- Satisfaction Guarantee*
- Proud Member of GOED
Save money with our Res-Q 2500 TG Omega-3 Mini Softgels – 3 Bottle Value Pack. Enjoy the convenience of not having to worry about running out of this supplement anytime soon!
SATISFACTION MONEY-BACK GUARANTEE
If you are not completely satisfied with your Res-Q 2500 TG Omega-3 Mini Softgels Value 3-Pack simply return it within 60 days of purchase and we will refund your product purchase.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. It is recommended that a physician be consulted before taking any supplements. Results not typical and may vary.
Research
- Berger et al. “Metabolic and nutritional support in acute cardiac failure.” Curr Opin Clin Nutr Metab Care. 2003 Mar; 6(2):195-201
- Nair SS, et al. “Prevention of cardiac arrhythmia by dietary (n-3) polyunsaturated fatty acids and their mechanism of action.” J Nutr. 1997 Mar;127(3):383-93
- De Caterina R. et al. “Antiarrhythmic effects of omega-3 fatty acids: from epidemiology to bedside.”. Am Heart J. 2003 Sep;146(3):420-30
- Bucher HC, et al. “N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials.” Am J Med. 2002;112:298-304
- Supari F., et al. “Fish oil treatment decreases superoxide anions in the myocardium and coronary arteries of atherosclerotic monkeys.” Circulation. 1995 Feb 15;91(4):1123-8
- Richter WO., et al. “Long-chain omega-3 fatty acids from fish reduce sudden cardiac death in patients with coronary heart disease.” Eur J Med Res. 2003 Aug 20;8(8):332-6
- Yli-Jama P. “Serum-free fatty acid pattern and risk of myocardial infarction: a case-control study.” J Intern Med. 2002 Jan;251(1):19-28
- Mozaffarian D, et al. “Effect of Fish Oil on Heart Rate in Humans…” Circulation. 2005 Sep 19 [Epub ahead of print]
- Paillard F. “Nutritional counseling for coronary and hypertensive patients.” Arch Mal Coeur Vaiss. 2003 Sep;96:27-33
- Armitage JA. “Increased blood pressure later in life may be associated with perinatal n-3 fatty acid deficiency.” Lipids. 2003 Apr;38(4):459-64
- Mori TA. et al. “Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans.” Hypertension. 1999;34:253-260
- Frenoux JM. et al. “A polyunsaturated fatty acid diet lowers blood pressure and improves antioxidant status in spontaneously hypertensive rats.” J Nutr. 2001 Jan;131(1):39-45
- Rousseau et al. “Dietary n-3 polyunsaturated fatty acids affect the development of renovascular hypertension in rats.”. Mol Cell Biochem. 2001 Sep;225(1-):109-19
- Morris MCB. “Does fish oil lower blood pressure? A meta-analysis of controlled trials.” Circulation 1993
- Curtis CL. “Effects of n-3 fatty acids on cartilage metabolism.” Proc Nutr Soc. 2002 Aug;61(3):381-9
- James MJ et al. “Dietary omega-3 fats as adjunctive therapy in a prototypic inflammatory disease: issues and obstacles for use in rheumatoid arthritis.” Prostaglandins Leukot Essent Fatty Acids. 2003 Jun;68(6):399-405
- Simopoulos AP. “Omega-3 fatty acids in inflammation and autoimmune diseases.” J Am Coll Nutr. 2002 Dec;21(6):495-505
- Cleland LG. “The role of fish oils in the treatment of rheumatoid arthritis.” Drugs. 2003;63(9):845-53
- Durrington PN, et al. “An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia.” Heart. 2001;85:544–548
- “The effect of a diet enriched with omega-3 polyunsaturated fatty acids on the indices of the blood fibrinolytic system in patients in the initial stages of ischemic heart disease.” Kardiologiia. 1993;33(6):21-5
- Saynor R. et al. “The long-term effect of dietary supplementation with fish lipid concentrate on serum lipids, bleeding time, platelets, and angina.” Atherosclerosis. 1984 Jan;50(1):3-10
- Menendez JA. “Overexpression and hyperactivity of breast cancer associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues, but it is selectively inhibited by tumoricidal alpha-linolenic and gammalinolenic fatty acids…” Int J Oncol. 2004 Jun;24.)
- Nkondjock A. “Intake of specific carotenoids and essential fatty acids and breast cancer risk in Montreal, Canada.” Am J Clin Nutr. 2004 May;79
- Jordan A. “Effect of an omega-3 fatty acid containing lipid emulsion alone and in combination with 5-fluorouracil (5-FU) on growth of the colon cancer cell line Caco-2.” Eur J Nutr. 2003 Dec;42(6):324-31
- Hardman WE, et al. “Consumption of an omega-3 fatty acids product, INCELL AAFA, reduced side-effects of CPT-11 (irinotecan) in mice.” Br J Cancer. 2002;86:983-988
- Holness MJ. “Acute omega-3 fatty acid enrichment selectively reverses high-saturated fat feeding-induced insulin hypersecretion but does not improve peripheral insulin resistance.” Diabetes. 2004 Feb;53 Suppl 1
- Simoncikova P. “Comparison of the extrapancreatic action of gammalinolenic acid and n-3 PUFAs in the high fat diet-induced insulin resistance [corrected].” Endocr Regul. 2002 Nov;36 28. Shimura T. “Docosahexanoic acid (DHA) improved glucose and lipid metabolism in KK-Ay mice with genetic non-insulin-dependent diabetes mellitus (NIDDM).” Biol Pharm Bull. 1997 May;20
- Holness MJ. “Diabetogenic impact of long-chain omega-3 fatty acids on pancreatic beta-cell function and the regulation of endogenous glucose production.” Endocrinology. 2003 Sep;1
- “Resistance to Leptin Contributes to Obesity.” The Rockefeller University. 1997, Aug. 5
- Kruger MC, et al. “Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis.” Aging (Milano).1998;10:385–394
- Albertazzi P, et al. “Polyunsaturated fatty acids. Is there a role in postmenopausal osteoporosis prevention?” Maturitas. 2002 May 20;42(1):13-22
- Terano T. “Effect of omega 3 polyunsaturated fatty acid ingestion on bone metabolism and osteoporosis.” World Rev Nutr Diet. 2001;88:141-7
- Högström, M et al. “n–3 Fatty acids are positively associated with peak bone mineral density and bone accrual in healthy men: the NO2 Study.” Am J Clin Nutr. 2007 85: 803-807
- Morris MC. “Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease.” Arch Neurol. 2003 Jul;60
- Hashimoto M. “Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer’s disease model rats.” J Neurochem. 2002 Jun;81
- Farooqu AA. “Plasmalogens, phospholipase A2, and docosahexaenoic acid turnover in brain tissue.” J Mol Neurosci. 2001 Apr-Jun;16.
- Malcolm Peet. “Essential fatty acids theoretical aspects and treatment implications for schizophrenia and depression.” Advances in Psychiatric Treatment 2002; 8 223-229
- Murck H. “Ethyl-eicosapentaenoate and dexamethasone resistance in therapy-refractory depression.” Int J Neuropsychopharmacol. 2004 Jun;:1-9
- Nemets B, et al. “Addition of Omega-3 Fatty Acid to Maintenance Medication Treatment for Recurrent Unipolar Depressive Disorder.” American Journal of Psychiatry 2002;159 477-479
- Tsekos E. “Perioperative administration of parenteral fish oil supplements in a routine clinical setting improves patient outcome after major abdominal surgery.” Clin Nutr. 2004 Jun;23
- Switzer KC. (n-3) Polyunsaturated fatty acids promote activation-induced cell death in murine T lymphocytes.” J Nutr. 2003 Feb;133
- Walton AJE, et al. “Dietary fish oil and the severity of symptoms in patients with systemic lupus erythematosus.” Ann Rheum Dis. 1991;50:463–466
- Cho E, et al. “Prospective study of dietary fat and the risk of age-related macular degeneration.” Am J Clin Nutr. 2001 Feb;73(2):209-18
- Seddon JM, et al. “Dietary fat and risk for advanced age-related macular degeneration.” Arch Opthalmol. 2001;119(8):1191-1199
- Seddon JM. “Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake.” Arch Ophthalmol. 2003 Dec;121(12):1728-37
How should I take Res-Q 2500 TG omega-3 fish oil?
Adults take 4-6 capsules daily. Take 2-3 capsules in the morning and 2-3 capsules in the evening. For larger doses please consult a healthcare practitioner.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. It is recommended that a physician be consulted before taking any supplements. Results not typical and may vary.
Supplement Facts
Suggested Use
Adults take 4-6 capsules daily.
Take 2-3 capsules in the morning and 2-3 capsules in the evening. For larger doses, please consult a healthcare practitioner.